These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 15630727

  • 1. Relapse in a population based cohort of patients with polymyalgia rheumatica.
    Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE.
    J Rheumatol; 2005 Jan; 32(1):65-73. PubMed ID: 15630727
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.
    Maradit Kremers H, Reinalda MS, Crowson CS, Davis JM, Hunder GG, Gabriel SE.
    Arthritis Rheum; 2007 Mar 15; 57(2):279-86. PubMed ID: 17330277
    [Abstract] [Full Text] [Related]

  • 3. Direct medical costs of polymyalgia rheumatica.
    Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE.
    Arthritis Rheum; 2005 Aug 15; 53(4):578-84. PubMed ID: 16082650
    [Abstract] [Full Text] [Related]

  • 4. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis.
    Narváez J, Nolla-Solé JM, Clavaguera MT, Valverde-García J, Roig-Escofet D.
    J Rheumatol; 1999 Sep 15; 26(9):1945-52. PubMed ID: 10493675
    [Abstract] [Full Text] [Related]

  • 5. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    González-Gay MA, García-Porrúa C, Vázquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE.
    J Rheumatol; 1999 Jun 15; 26(6):1326-32. PubMed ID: 10381051
    [Abstract] [Full Text] [Related]

  • 6. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, Padula A, Boiardi L.
    Semin Arthritis Rheum; 2000 Aug 15; 30(1):17-24. PubMed ID: 10966209
    [Abstract] [Full Text] [Related]

  • 7. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
    Uddhammar A, Eriksson AL, Nyström L, Stenling R, Rantapää-Dahlqvist S.
    J Rheumatol; 2002 Apr 15; 29(4):737-42. PubMed ID: 11950015
    [Abstract] [Full Text] [Related]

  • 8. Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease.
    Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE.
    Arthritis Rheum; 2005 Jun 15; 53(3):395-403. PubMed ID: 15934100
    [Abstract] [Full Text] [Related]

  • 9. Peripheral musculoskeletal manifestations in polymyalgia rheumatica.
    Ceccato F, Roverano SG, Papasidero S, Barrionuevo A, Rillo OL, Paira SO.
    J Clin Rheumatol; 2006 Aug 15; 12(4):167-71. PubMed ID: 16891918
    [Abstract] [Full Text] [Related]

  • 10. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
    Proven A, Gabriel SE, O'Fallon WM, Hunder GG.
    J Rheumatol; 1999 Jun 15; 26(6):1333-7. PubMed ID: 10381052
    [Abstract] [Full Text] [Related]

  • 11. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE.
    J Rheumatol; 2006 Feb 15; 33(2):248-55. PubMed ID: 16358365
    [Abstract] [Full Text] [Related]

  • 12. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG.
    J Rheumatol; 2000 Sep 15; 27(9):2179-84. PubMed ID: 10990231
    [Abstract] [Full Text] [Related]

  • 13. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M, Catanoso MG, Pulsatelli L, Meliconi R, Boiardi L.
    Arthritis Rheum; 2005 Feb 15; 53(1):33-8. PubMed ID: 15696567
    [Abstract] [Full Text] [Related]

  • 14. Polymyalgia rheumatica.
    Salvarani C, Cantini F, Boiardi L, Hunder GG.
    Best Pract Res Clin Rheumatol; 2004 Oct 15; 18(5):705-22. PubMed ID: 15454128
    [Abstract] [Full Text] [Related]

  • 15. [Follow-up studies in polymyalgia rheumatica and temporal arteritis].
    Li J, Tang FL, Wang XD, Yu JH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec 15; 24(6):643-5. PubMed ID: 12905697
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE.
    Arthritis Rheum; 2005 Mar 15; 52(3):722-32. PubMed ID: 15751097
    [Abstract] [Full Text] [Related]

  • 17. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis.
    Lundberg I, Hedfors E.
    J Rheumatol; 1990 Oct 15; 17(10):1340-5. PubMed ID: 2254893
    [Abstract] [Full Text] [Related]

  • 18. [Polymyalgia rheumatica].
    Kaposi Novák P, Schmidt Z.
    Orv Hetil; 2006 Sep 17; 147(37):1791-802. PubMed ID: 17131799
    [Abstract] [Full Text] [Related]

  • 19. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
    Leeb BF, Rintelen B, Sautner J, Fassl C, Bird HA.
    Arthritis Rheum; 2007 Jun 15; 57(5):810-5. PubMed ID: 17530664
    [Abstract] [Full Text] [Related]

  • 20. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE.
    Arthritis Rheum; 2005 Feb 15; 52(2):402-11. PubMed ID: 15693010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.